How proposed act would affect biotech industry

The cost of litigation is crippling the industry. Certain companies are taking advantage of administrative rules to further their own ends. Damage awards are out of control. So go the typical rationales trotted out to support new legislation; so go the rationales for supporting the proposed Patent R...

Full description

Saved in:
Bibliographic Details
Published in:The National Law Journal 2006-04, Vol.27 (82), p.S3
Main Author: McKinney, Jeffrey A
Format: Article
Language:English
Subjects:
Amino acids
Biotechnology industry
Federal legislation
Fraud
Inventors
Legal fees
Litigation
Polypeptides
Regulatory reform
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The cost of litigation is crippling the industry. Certain companies are taking advantage of administrative rules to further their own ends. Damage awards are out of control. So go the typical rationales trotted out to support new legislation; so go the rationales for supporting the proposed Patent Reform Act of 2005. There is almost always at least a grain of truth in such rationales, and the ones underpinning the proposed act are no exception. The difficult part is determining the percentage of truth in particular statements, which can only be approached by closely examining the various legislative subsections in view of a particular industry sector.
ISSN:2163-8756